SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr | ₹6,170 Cr | ₹6,555 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹12,135 Cr |
Mar2023 | ₹4,959 Cr |
Mar2022 | ₹8,985 Cr |
Mar2021 | ₹6,170 Cr |
Mar2020 | ₹6,555 Cr |
How is Cash Flow from Operating Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹12,135 Cr | 144.69 | |
Mar2023 | ₹4,959 Cr | -44.80 | |
Mar2022 | ₹8,985 Cr | 45.61 | |
Mar2021 | ₹6,170 Cr | -5.86 | |
Mar2020 | ₹6,555 Cr | - |
Compare Cash Flow from Operating Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹416,386.5 Cr | -3% | 5.6% | 9.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | 1% | 2.7% | 70.3% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -2.7% | 0.4% | -0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | 0.1% | 7.2% | 25.7% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2% | 7.1% | 8.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -3.1% | -0.2% | -6.2% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -3% |
5.6% |
9.3% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses